LG 100268 is a potent RXR agonist for evaluation in the treatment of non-insulin-dependent (type II) diabetes mellitus (NIDDM).Synonyms:6-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl]-3-Pyridinecarboxylic Acid; AGN 192620; ALRT 268; CD 3127; LG 268; LGD 100268; LGD 1268;CAS Number:153559-76-3Molecular Formula:C₂₄H₂₉NO₂Molecular Weight:363.49Appearance:Off-White SolidMelting Point:276-278ºC (dec.)Solubility:Chloroform (Slightly), Methanol (Slightly)Storage:-20°C Freezer